Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHYF | NRXP | ALDX | ||
| Company | Innate Pharma | Nrx Pharmaceuticals Inc | Aldeyra Therapeu | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 1.6500 | 3.91 | 2.41 | ||
| High | 1.6500 | 3.99 | 2.53 | ||
| Low | 1.6500 | 3.80 | 2.25 | ||
| Latest | 1.6500 | 3.87 | 2.27 | ||
| Change | -0.6000 | +0.01 | -0.16 | ||
| % Change | -26.67% | +0.26% | -6.58% | ||
| Volume | 6,700 | 668,700 | 2,118,600 | ||
| 20-Day Average Volume | N/A | 1,111,550 | 1,841,230 | ||
| Previous Close | 2.2500 | 3.86 | 2.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 3.91 | 1.89 | ||
| 20-Day Raw Stochastic | N/A | 59.23% | 71.58% | ||
| 20-Day Relative Strength | N/A | 53.74 | 59.90 | ||
| Weighted Alpha | N/A | +21.40 | -10.46 | ||
| Today's Opinion | N/A | 88% Buy | 40% Sell | ||
| Previous Opinion | N/A | 88% Buy | 40% Sell | ||
| Last Month's Opinion | N/A | 88% Buy | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -26.67% since 05/14/26 | +8.71% since 06/25/26 | +26.11% since 06/25/26 | ||
| Low | 1.6500 on 05/27/26 | 3.49 on 06/26/26 | 1.71 on 06/26/26 | ||
| High | 1.6500 on 05/27/26 | 4.18 on 06/30/26 | 2.53 on 07/01/26 | ||
| 1-Month | |||||
| %Chg | +10.00% since 04/14/26 | -16.23% since 06/02/26 | +38.41% since 06/02/26 | ||
| Low | 1.6500 on 05/27/26 | 3.10 on 06/24/26 | 1.59 on 06/03/26 | ||
| High | 2.2500 on 05/14/26 | 4.40 on 06/09/26 | 2.53 on 07/01/26 | ||
| 3-Month | |||||
| %Chg | N/A since 03/23/26 | +75.91% since 04/02/26 | +36.75% since 04/02/26 | ||
| Low | 1.3725 on 03/23/26 | 2.11 on 04/07/26 | 1.47 on 04/29/26 | ||
| High | 2.2500 on 05/14/26 | 5.05 on 06/02/26 | 2.53 on 07/01/26 | ||
| 6-Month | |||||
| %Chg | N/A since 03/23/26 | +47.71% since 01/02/26 | -51.39% since 01/02/26 | ||
| Low | 1.3725 on 03/23/26 | 1.62 on 03/09/26 | 1.07 on 03/17/26 | ||
| High | 2.2500 on 05/14/26 | 5.05 on 06/02/26 | 5.93 on 01/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 138,320 | 140,206 | 136,929 | ||
| Shares Outstanding, K | 83,830 | 36,229 | 60,321 | ||
| Annual Sales | 10,190,000 | 1,230,000 | 0 | ||
| Annual Net Income | -55,640,000 | -28,620,000 | -33,850,000 | ||
| Last Quarter Sales | N/A | 1,070,000 | 0 | ||
| Last Quarter Net Income | N/A | -1,430,000 | -3,450,000 | ||
| 60-Month Beta | 0.25 | 2.19 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.04 on 05/15/26 | -0.06 on 05/07/26 | ||
| Earnings Date | 05/13/26 | 08/17/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||